Industry

Diverse group of ADHD specialists identifies key challenges facing providers, patients and families, and solutions for improving quality of care ATLANTA–(BUSINESS WIRE)–The ADHD Expert Consortium, a group of ADHD experts comprised of psychiatrists, psychologists, neurologists, pediatricians, nurse practitioners, neuropsychologists and patient advocates, has issued a consensus statement detailing needed improvements for the future of ADHD … [Read more…]

NEW YORK–(BUSINESS WIRE)–Shanghai Rongtai Health Technology Corporation Limited (RONGTAI) has recently announced its latest product pre-sale – the G20 Marvel co-branded massage gun series on the crowdfunding platform Indiegogo on June 30, 2022. Founded in 1997, RONGTAI is a leader in China’s health equipment industry. The brand aims to enhance the convenient and comfortable lifestyle … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced a poster on the ongoing international Phase 3 PHOENIX trial (study A35-004, NCT05021536) of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO; also known as ursodoxicoltaurine]) in people living with amyotrophic lateral sclerosis (ALS) will be presented on Saturday, July 9, at the … [Read more…]

SAN ANTONIO, Texas–(BUSINESS WIRE)–#CriticalCare–Turn Medical, a medical device company and the manufacturer of the Pronova-O2™ Automated Prone Therapy System, has received the Breakthrough Technology Award and a group purchasing agreement with Premier, Inc. Effective July 1, 2022, through February 28, 2025, the new agreement allows Premier members, at their discretion, to take advantage of special … [Read more…]

Veteran Digital Health and Sales Leader to Lead Transcarent’s Expansion into Self-Insured Employer Market, including Health Systems and Government Entities PALO ALTO, Calif.–(BUSINESS WIRE)–Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families, today announced the appointment of Peter Bridges as its new Chief Commercial Officer. … [Read more…]

Funding will support community-based initiatives aiming to boost African American childhood development and improve educational achievement gaps MINNEAPOLIS–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, awarded a $150,000 grant to the African American Babies Coalition and Projects (Wilder AABC) in support of its initiatives to educate the community, recruit child care professionals and develop programs … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway’s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent … [Read more…]

  SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders, today announced the appointment of Bob Deresiewicz, M.D., to its Board of Directors. Dr. Deresiewicz is a recently retired partner, portfolio manager and global industry analyst with Wellington Management Company, LLP. … [Read more…]

BOSTON–(BUSINESS WIRE)–#medtech–Over 120 female senior medtech executives gathered on June 14 for MedExecWomen’s annual conference: “Into the Future: New Healthcare Partnerships to Drive Value.” MedExecWomen, co-founded in 2019 by Laurie Halloran, president & CEO of Halloran Consulting Group, and Maria Shepherd, president & founder of Medi-Vantage, empowers women in leadership roles in the medical device, … [Read more…]

IMM-BCP-01 neutralized BA.4/.5 and BA.2.12.1 subvariants in pseudovirus testing IMM-BCP-01 currently in Phase 1b clinical testing with topline data expected in 2H 2022 EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that their cocktail (IMM-BCP-01) retained activity … [Read more…]